These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Improving opportunities for effective management of gastro-oesophageal reflux disease. Vigneri S; Tonini M; Scarpignato C; Savarino V Dig Liver Dis; 2001 Nov; 33(8):720-30. PubMed ID: 11785720 [TBL] [Abstract][Full Text] [Related]
15. Intragastric acidity during administration of generic omeprazole or esomeprazole - a randomised, two-way crossover study including CYP2C19 genotyping. Miehlke S; Löbe S; Madisch A; Kuhlisch E; Laass M; Grossmann D; Knoth H; Morgner A; Labenz J Aliment Pharmacol Ther; 2011 Feb; 33(4):471-6. PubMed ID: 21175704 [TBL] [Abstract][Full Text] [Related]
16. Esomeprazole: a review of its use in the management of acid-related disorders in the US. Scott LJ; Dunn CJ; Mallarkey G; Sharpe M Drugs; 2002; 62(7):1091-118. PubMed ID: 11985491 [TBL] [Abstract][Full Text] [Related]
17. Dose-response relationship of lansoprazole to gastric acid antisecretory effects. Blum RA; Hunt RH; Kidd SL; Shi H; Jennings DE; Greski-Rose PA Aliment Pharmacol Ther; 1998 Apr; 12(4):321-7. PubMed ID: 9690720 [TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacology and safety profile of esomeprazole, the first enantiomerically pure proton pump inhibitor. Tonini M; Vigneri S; Savarino V; Scarpignato C Dig Liver Dis; 2001 Oct; 33(7):600-6. PubMed ID: 11816552 [TBL] [Abstract][Full Text] [Related]
20. The anti-secretory and anti-ulcer activities of esomeprazole in comparison with omeprazole in the stomach of rats and rabbits. Bastaki SM; Chandranath IS; Singh J Mol Cell Biochem; 2008 Feb; 309(1-2):167-75. PubMed ID: 18044010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]